Insurance reimbursements for medical cannabinoid products in Germany continued to grow in the first quarter of 2023, showing that Europe’s largest economy continues to see a gradual expansion of its cannabis industry – now one of the largest in the world.
Reimbursements reached roughly 50.9 million euros ($55.6 million) in the January-March quarter, according to the latest data from the German National Association of Statutory Health Insurance Funds (GKV-Spitzenverband).
ADVERTISEMENT
That marks a 6.5% increase compared to the same period last year, but it’s a small decline compared to the fourth quarter of 2022.
Almost 99,000 prescriptions were filled in the quarter.
The dried-flower segment consisted of 21.1 million euros in sales.
Finished pharmaceutical products, a category consisting of products such as Sativex and Epidolex, recorded sales of 13.1 million euros.
For comparison, Canada’s regulated market recorded medical cannabis sales of 98 million Canadian dollars ($72
Read full article on Marijuana Business Daily
